Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Gilgamesh Pharmaceuticals
Gilgamesh Pharmaceuticals is a clinical-stage neuroscience biotech focused on developing innovative new chemical entities (NCEs) that transform psychiatric disease treatment from symptom management…
Gilgamesh Pharmaceuticals
Gilgamesh Pharmaceuticals is a clinical-stage neuroscience biotech focused on developing innovative new chemical entities (NCEs) that transform psychiatric disease treatment from symptom management…
TL;DR
Stage: Clinical-stage neuroscience biotech
Focus: Rapid-acting, durable therapies for psychiatric disorders
Lead programs: Bretisilocin (GM-2505) and Blixeprodil (GM-1020)
Founded: 2019
Approx. team: 36 employees
Notable backers: Y Combinator, Prime Movers Lab, NIDA
Company Overview
Problem Domain
Neuropsychiatric disorders (depression, anxiety, opioid use disorder, PTSD, traumatic brain injury)
Founded
2019
Industry
Biotechnology
Funding Track Record
60,000,000
Reported $60M Series A to advance neuropsychiatric therapies
Investor Signal
“Backed by institutional and accelerator investors including Y Combinator, Prime Movers Lab, and grant funding from the U.S. National Institute on Drug Abuse (NIDA)”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,300+
New This Week